Page last updated: 2024-08-17

17-alpha-hydroxyprogesterone and Recrudescence

17-alpha-hydroxyprogesterone has been researched along with Recrudescence in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (40.00)29.6817
2010's6 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elovitz, MA; Levine, LD; Purisch, SE; Turitz, AL1
Cruz Ortiz, SG; Llorens, A; Pereira, OM; Rosa, ER1
Chen, L; Cheng, J; Huang, Y; Li, X; Liu, L; Lu, S; Xiao, Q; Xie, T; Zheng, J1
Bastek, JA; Elovitz, MA; Levine, LD; Purisch, SE; Turitz, AL1
Desch, CN; Istwan, NB; Joy, S; Rhea, DJ; Stanziano, G1
Iams, JD1
Carbonne, B; Rosenblatt, J1
Caritis, SN; Carpenter, M; Conway, D; Dombrowski, MP; Gabbe, S; Hauth, JC; Iams, JD; Leveno, KJ; Meis, PJ; Mercer, B; Miodovnik, M; Moawad, AH; O'Sullivan, MJ; Peaceman, AM; Ramin, SM; Sibai, B; Spong, CY; Thom, EA; Thorp, JM; Varner, MW; Wapner, RJ1
Cleary-Goldman, J; Istwan, NB; Rebarber, A; Rhea, DJ; Russo-Stieglitz, K; Saltzman, DH; Stanziano, GJ1
Bailey, EM; Oliver, JW; Schneider, JF; Wagner, RA1

Reviews

1 review(s) available for 17-alpha-hydroxyprogesterone and Recrudescence

ArticleYear
[Prevention of recurrent preterm birth: a comeback for progesterone?].
    Journal de gynecologie, obstetrique et biologie de la reproduction, 2005, Volume: 34, Issue:1 Suppl

    Topics: 17-alpha-Hydroxyprogesterone; Female; Humans; Obstetric Labor, Premature; Pregnancy; Randomized Controlled Trials as Topic; Recurrence; Risk Factors

2005

Other Studies

9 other study(ies) available for 17-alpha-hydroxyprogesterone and Recrudescence

ArticleYear
The Effect of Prior Term Birth on Risk of Recurrent Spontaneous Preterm Birth.
    American journal of perinatology, 2018, Volume: 35, Issue:4

    Topics: 17-alpha-Hydroxyprogesterone; Adult; Birth Order; Female; Gestational Age; Humans; Infant, Newborn; Logistic Models; Multivariate Analysis; Pennsylvania; Pregnancy; Pregnancy Outcome; Premature Birth; Recurrence; Retrospective Studies; Risk Factors; Term Birth; Young Adult

2018
Pregnancy and neonatal outcomes of women receiving compounded 17-alpha hydroxyprogesterone at San Juan City hospital.
    Boletin de la Asociacion Medica de Puerto Rico, 2013, Volume: 105, Issue:3

    Topics: 17-alpha-Hydroxyprogesterone; Adult; Birth Weight; Drug Evaluation; Female; Gestational Age; Home Care Services, Hospital-Based; Humans; Infant, Newborn; Infant, Premature; Injections, Intramuscular; Male; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Premature Birth; Puerto Rico; Recurrence; Stillbirth; Tocolytic Agents; Urban Population

2013
[A novel homozygous mutation p.E25X in the HSD3B2 gene causing salt wasting 3β-hydroxysteroid dehydrogenases deficiency in a Chinese pubertal girl: a delayed diagnosis until recurrent ovary cysts].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2014, Volume: 52, Issue:12

    Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Androstenedione; China; Codon, Nonsense; Delayed Diagnosis; Female; Follicle Stimulating Hormone; Homozygote; Humans; Hydrocortisone; Luteinizing Hormone; Mutation; Ovarian Cysts; Progesterone Reductase; Recurrence; Retrospective Studies

2014
Patient characteristics associated with 17-alpha hydroxyprogesterone caproate use among a high-risk cohort.
    American journal of obstetrics and gynecology, 2016, Volume: 214, Issue:4

    Topics: 17-alpha-Hydroxyprogesterone; Adult; Cerclage, Cervical; Cross-Sectional Studies; Female; Fetal Death; Humans; Patient Acceptance of Health Care; Pennsylvania; Pregnancy; Pregnancy, High-Risk; Premature Birth; Progestins; Recurrence

2016
The risk for preterm labor in women receiving 17 alpha-hydroxyprogesterone caproate prophylaxis for preterm birth prevention.
    American journal of perinatology, 2010, Volume: 27, Issue:4

    Topics: 17-alpha-Hydroxyprogesterone; Adult; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fetal Monitoring; Follow-Up Studies; Gestational Age; Humans; Infant, Newborn; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Pregnancy, High-Risk; Premature Birth; Probability; Recurrence; Retrospective Studies; Risk Assessment

2010
Was the preterm birth rate in the placebo group too high in the Meis MFMU Network trial of 17-OHPC?
    American journal of obstetrics and gynecology, 2010, Volume: 202, Issue:5

    Topics: 17-alpha-Hydroxyprogesterone; Castor Oil; Female; Humans; Oxytocin; Pregnancy; Pregnancy Trimester, Third; Premature Birth; Randomized Controlled Trials as Topic; Recurrence; Risk Assessment; Risk Factors; Uterine Contraction

2010
Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery.
    American journal of obstetrics and gynecology, 2005, Volume: 193, Issue:3 Pt 2

    Topics: 17-alpha-Hydroxyprogesterone; Female; Gestational Age; Humans; Logistic Models; Pregnancy; Premature Birth; Proportional Hazards Models; Recurrence

2005
Increased incidence of gestational diabetes in women receiving prophylactic 17alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery.
    Diabetes care, 2007, Volume: 30, Issue:9

    Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Caproates; Diabetes, Gestational; Female; Humans; Incidence; Injections, Intramuscular; Pregnancy; Premature Birth; Recurrence; Tocolytic Agents

2007
Leuprolide acetate treatment of adrenocortical disease in ferrets.
    Journal of the American Veterinary Medical Association, 2001, Apr-15, Volume: 218, Issue:8

    Topics: 17-alpha-Hydroxyprogesterone; Adrenal Cortex Diseases; Aggression; Androstenedione; Animals; Dehydroepiandrosterone Sulfate; Estradiol; Ferrets; Leuprolide; Recurrence; Safety; Sexual Behavior, Animal; Time Factors; Treatment Outcome

2001